Nucky
06-17-2021, 03:41 PM
Please if you use a CPAP or Bipap machine check out this story and Google for other stories. Compiling information on your own and making your own decision seems to be the path after a full day of bouncing around on the phone between Apria, My Pulmonary Doctor, and United Health Care.
It is a very serious situation. Best of luck with your decision on continuing respiratory therapy or trying to go without it because of the chance of a carcinogen being released into your lungs.
I did my best here. I'm not a Doctor.
Medical Device recall notification (U.S. only) / field safety notice (International Markets)
Philips Respironics
There is nothing we take more seriously than providing patients with high-quality products that are safe and reliable. If an issue arises, we are proactive in communicating and addressing it as we work tirelessly towards a resolution.
On April 26, 2021, Philips provided an important update regarding proactive efforts to address identified issues with a component in certain products of our Sleep & Respiratory Care portfolio.
At that time, out of an abundance of caution and based on available information, Philips advised of potential health risks related to sound abatement foam used in specific Philips Continuous Positive Airway Pressure (CPAP), BiLevel Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators.
The company also indicated that analysis of potential health risks was ongoing and that further information would be provided when available. As a result of extensive ongoing review following this announcement, on June 14, 2021, the company issued a recall notification (U.S. only) / field safety notice (International Markets) for specific affected devices.
The recall notification (U.S. only) / field safety notice (International Markets) informs customers and users of potential impacts on patient health and clinical use related to this issue, as well as instructions on actions to be taken. Additionally, the notification provides details of our robust and comprehensive repair and replacement program, to correct this issue as efficiently and thoroughly as possible.
The recall notification (U.S. only) / field safety notice (International Markets) advises patients and customers to take the following actions:
For patients using life-sustaining mechanical ventilator devices:
Do not stop or alter your prescribed therapy until you have talked to your physician. Philips recognizes that alternate ventilator options for therapy may not exist or may be severely limited for patients who require a ventilator for life-sustaining therapy, or in cases where therapy disruption is unacceptable. In these situations, and at the discretion of the treating clinical team, the benefit of continued usage of these ventilator devices may outweigh the risks.
If your physician determines that you must continue using this device, use an inline bacterial filter. Consult your Instructions for Use for guidance on installation.
For patients using BiLevel PAP and CPAP devices:
Discontinue use of your device and work with your physician or Durable Medical Equipment (DME) provider to determine the most appropriate options for continued treatment.
We cannot stress enough that Philips is treating this matter with the highest possible seriousness, and are dedicating significant time and resources to address this issue. Our intention is to give affected patients and customers the service they expect and deserve as we resolve this matter as our top priority.
This effort includes wide-scale, global ramping up of manufacturing, repair, services, supply chain, and other functions to support the correction.
We are absolutely committed to supporting the worldwide community of patients who rely on our Sleep & Respiratory Care solutions for their health and quality of life, and the physicians and customers who are dedicated to meeting patient needs.
What you need to do
What devices are affected
Questions and answers
Help
Questions? Call
877-907-7508
Toll-free in the USA
Outside the USA call
(0044) 20 8089 3822
Begin registration process
Recall notification (U.S. only) / field safety notice (International Markets) (137.0KB)
What you need to do
Philips is committed to rectifying this issue through a robust and comprehensive repair and replacement program. We have established a claims processing and support center to assist you.
Icon Business
Durable Medical Equipment Providers, Distributors, or Medical Institutions​
Click the link below to begin our registration process. If you are in the United States, you will receive a letter by June 23, 2021, from Philips about this issue that contains log-in credentials for the registration website. If you are located outside of the United States, you will receive the letter shortly thereafter. If you do not receive this letter, please call the number below.
After registration, we will notify you with additional information as it becomes available.
Begin registration process
877-907-7508
Downloadable resources
Template web copy block for DME and HCP use (26.0KB)
FAQs (193.0KB)
Physician engagement letter for DME and HCP use (82.0KB)
Icon Patient
Patients, Users, or Caregivers​
Philips has established a registration process that allows Patients, Users, or Caregivers​ to look up their device serial number and begin a claim if their unit is affected.
At this time, this process is only available for Patients, Users, or Caregivers in the USA and Canada. More countries will be added shortly.
Begin registration process
877-907-7508
Icon Medical professional
Physicians and other medical care providers​
Click the link below for additional clinical details on the issue and other information to help you advise your patients who have been impacted.
Learn more
Back to top
What devices are affected by the recall notification (U.S. only) / field safety notice (International Markets)?
The recall notification (U.S. only) / field safety notice (International Markets) provides customers with information on how to identify affected products.
Additionally, the device Instructions for Use provide product identification information to assist with this activity.
Products affected by this recall notification (U.S. only) / field safety notice (International Markets) include:
CPAP and BiLevel PAP Devices
All Affected Devices Manufactured Before 26 April 2021, All Device Serial Numbers
Continuous Ventilator, Minimum Ventilatory Support, Facility Use
E30
E30
(Emergency Use Authorization)
Continuous Ventilator, Non-life Supporting
DreamStation ASV
DreamStation
ASV
DreamStation AVAPS
DreamStation
ST, AVAPS
60 Series CPAP, ASV
SystemOne
ASV4
C Series AVAPS/ST
C Series
ASV, S/T, AVAPS
OmniLab Advanced Plus(sleep lab) CPAP
OmniLab Advanced Plus
In-Lab Titration Device
Non-continuous Ventilator
60 Series CPAP, ASV
SystemOne
(Q series)
DreamStation CPAP
DreamStation
CPAP, Auto CPAP, BiPAP
DreamStation Go
DreamStation GO
CPAP, APAP
Dorma 400, 500
Dorma 400, 500
CPAP
REMStar SE Auto CPAP
REMStar SE Auto
CPAP
Mechanical Ventilators
All Affected Devices Manufactured Before 26 April 2021, All Device Serial Numbers
Continuous Ventilator
Trilogy 100
Trilogy 100
Ventilator
Trilogy 200
Trilogy 200
Ventilator
Trilogy 200
Garbin Plus, Aeris, LifeVent
Ventilator
Continuous Ventilator, Minimum Ventilatory Support, Facility Use
A 40/30
A-Series BiPAP Hybrid A30
(not marketed in US)
V30
A-Series BiPAP V30 Auto
Ventilator
Continuous Ventilator, Non-life Supporting
A 40/30
A-Series BiPAP A40
(not marketed in US)
A 40/30
A-Series BiPAP A30
(not marketed in US)
What products are not affected and why?
Products that are not affected may have different sound abatement foam materials, as new materials and technologies are available over time. Also, sound abatement foam in unaffected devices may be placed in a different location due to device design.
Products not affected by this recall notification (U.S. only) / field safety notice (International Markets) include:
Trilogy Evo
Trilogy Evo OBM
Trilogy EV300
Trilogy 202
BiPAP A40 EFL
BiPAP A40 Pro
M-Series
DreamStation 2
Omnilab (original based on Harmony 2)
Dorma 100, Dorma 200, & REMStar SE
All oxygen concentrators, respiratory drug delivery products, airway clearance products.
Back to top
Questions and answers
Are affected devices safe for use? Should affected devices be removed from service?
The recall notification (U.S. only) / field safety notice (International Markets) advises patients and customers to take the following actions:
For patients using BiLevel PAP and CPAP devices: Discontinue use of affected units and consult with physicians to determine the benefits of continuing therapy and potential risks.
For patients using life-sustaining mechanical ventilator devices: DO NOT discontinue or alter prescribed therapy, without consulting physicians to determine appropriate next steps.
Philips is recommending that customers and patients halt use of ozone-related cleaning products, and adhere to their device Instructions for Use for approved cleaning methods.
Additionally, Philips is reminding customers and patients to review the age of their BiLevel PAP and CPAP devices, as they are typically recommended to be replaced after five years of use.
What is the safety hazard associated with this issue? Has Philips received any reports of patient harm due to this issue?
When will the correction for this issue begin? How long will it take to address all affected devices?
Are affected devices continuing to be manufactured and/or shipped?
Is this a recall? Have regulatory authorities classified the severity of the recall?
How will Philips address this issue? Are affected devices being replaced and/or repaired? Are customers entitled to a warranty replacement, repair, service, or other mitigations?
Are there any steps that customers, patients, users, and/or clinicians should take regarding this issue?
What is the cause of this issue? Was it a design, manufacture, supplier, or other problem?
How did this happen, and what is Philips doing to ensure it will not happen again?
What is meant by "high heat and humidity" being one of the causes of this issue?
Do affected units exhibit features that customers/users should watch out for? Particles or other visible issues?
Can Philips replace products under warranty or repair devices under warranty?
In those regions where Philips provides both patient care and devices, will new patients be set up with devices? Will existing patient devices that fail be replaced?
Is Philips certain that this issue is limited to the listed devices? Is there any possibility others are affected?
:pray: God Help Us!
It is a very serious situation. Best of luck with your decision on continuing respiratory therapy or trying to go without it because of the chance of a carcinogen being released into your lungs.
I did my best here. I'm not a Doctor.
Medical Device recall notification (U.S. only) / field safety notice (International Markets)
Philips Respironics
There is nothing we take more seriously than providing patients with high-quality products that are safe and reliable. If an issue arises, we are proactive in communicating and addressing it as we work tirelessly towards a resolution.
On April 26, 2021, Philips provided an important update regarding proactive efforts to address identified issues with a component in certain products of our Sleep & Respiratory Care portfolio.
At that time, out of an abundance of caution and based on available information, Philips advised of potential health risks related to sound abatement foam used in specific Philips Continuous Positive Airway Pressure (CPAP), BiLevel Positive Airway Pressure (BiLevel PAP) devices, and Mechanical Ventilators.
The company also indicated that analysis of potential health risks was ongoing and that further information would be provided when available. As a result of extensive ongoing review following this announcement, on June 14, 2021, the company issued a recall notification (U.S. only) / field safety notice (International Markets) for specific affected devices.
The recall notification (U.S. only) / field safety notice (International Markets) informs customers and users of potential impacts on patient health and clinical use related to this issue, as well as instructions on actions to be taken. Additionally, the notification provides details of our robust and comprehensive repair and replacement program, to correct this issue as efficiently and thoroughly as possible.
The recall notification (U.S. only) / field safety notice (International Markets) advises patients and customers to take the following actions:
For patients using life-sustaining mechanical ventilator devices:
Do not stop or alter your prescribed therapy until you have talked to your physician. Philips recognizes that alternate ventilator options for therapy may not exist or may be severely limited for patients who require a ventilator for life-sustaining therapy, or in cases where therapy disruption is unacceptable. In these situations, and at the discretion of the treating clinical team, the benefit of continued usage of these ventilator devices may outweigh the risks.
If your physician determines that you must continue using this device, use an inline bacterial filter. Consult your Instructions for Use for guidance on installation.
For patients using BiLevel PAP and CPAP devices:
Discontinue use of your device and work with your physician or Durable Medical Equipment (DME) provider to determine the most appropriate options for continued treatment.
We cannot stress enough that Philips is treating this matter with the highest possible seriousness, and are dedicating significant time and resources to address this issue. Our intention is to give affected patients and customers the service they expect and deserve as we resolve this matter as our top priority.
This effort includes wide-scale, global ramping up of manufacturing, repair, services, supply chain, and other functions to support the correction.
We are absolutely committed to supporting the worldwide community of patients who rely on our Sleep & Respiratory Care solutions for their health and quality of life, and the physicians and customers who are dedicated to meeting patient needs.
What you need to do
What devices are affected
Questions and answers
Help
Questions? Call
877-907-7508
Toll-free in the USA
Outside the USA call
(0044) 20 8089 3822
Begin registration process
Recall notification (U.S. only) / field safety notice (International Markets) (137.0KB)
What you need to do
Philips is committed to rectifying this issue through a robust and comprehensive repair and replacement program. We have established a claims processing and support center to assist you.
Icon Business
Durable Medical Equipment Providers, Distributors, or Medical Institutions​
Click the link below to begin our registration process. If you are in the United States, you will receive a letter by June 23, 2021, from Philips about this issue that contains log-in credentials for the registration website. If you are located outside of the United States, you will receive the letter shortly thereafter. If you do not receive this letter, please call the number below.
After registration, we will notify you with additional information as it becomes available.
Begin registration process
877-907-7508
Downloadable resources
Template web copy block for DME and HCP use (26.0KB)
FAQs (193.0KB)
Physician engagement letter for DME and HCP use (82.0KB)
Icon Patient
Patients, Users, or Caregivers​
Philips has established a registration process that allows Patients, Users, or Caregivers​ to look up their device serial number and begin a claim if their unit is affected.
At this time, this process is only available for Patients, Users, or Caregivers in the USA and Canada. More countries will be added shortly.
Begin registration process
877-907-7508
Icon Medical professional
Physicians and other medical care providers​
Click the link below for additional clinical details on the issue and other information to help you advise your patients who have been impacted.
Learn more
Back to top
What devices are affected by the recall notification (U.S. only) / field safety notice (International Markets)?
The recall notification (U.S. only) / field safety notice (International Markets) provides customers with information on how to identify affected products.
Additionally, the device Instructions for Use provide product identification information to assist with this activity.
Products affected by this recall notification (U.S. only) / field safety notice (International Markets) include:
CPAP and BiLevel PAP Devices
All Affected Devices Manufactured Before 26 April 2021, All Device Serial Numbers
Continuous Ventilator, Minimum Ventilatory Support, Facility Use
E30
E30
(Emergency Use Authorization)
Continuous Ventilator, Non-life Supporting
DreamStation ASV
DreamStation
ASV
DreamStation AVAPS
DreamStation
ST, AVAPS
60 Series CPAP, ASV
SystemOne
ASV4
C Series AVAPS/ST
C Series
ASV, S/T, AVAPS
OmniLab Advanced Plus(sleep lab) CPAP
OmniLab Advanced Plus
In-Lab Titration Device
Non-continuous Ventilator
60 Series CPAP, ASV
SystemOne
(Q series)
DreamStation CPAP
DreamStation
CPAP, Auto CPAP, BiPAP
DreamStation Go
DreamStation GO
CPAP, APAP
Dorma 400, 500
Dorma 400, 500
CPAP
REMStar SE Auto CPAP
REMStar SE Auto
CPAP
Mechanical Ventilators
All Affected Devices Manufactured Before 26 April 2021, All Device Serial Numbers
Continuous Ventilator
Trilogy 100
Trilogy 100
Ventilator
Trilogy 200
Trilogy 200
Ventilator
Trilogy 200
Garbin Plus, Aeris, LifeVent
Ventilator
Continuous Ventilator, Minimum Ventilatory Support, Facility Use
A 40/30
A-Series BiPAP Hybrid A30
(not marketed in US)
V30
A-Series BiPAP V30 Auto
Ventilator
Continuous Ventilator, Non-life Supporting
A 40/30
A-Series BiPAP A40
(not marketed in US)
A 40/30
A-Series BiPAP A30
(not marketed in US)
What products are not affected and why?
Products that are not affected may have different sound abatement foam materials, as new materials and technologies are available over time. Also, sound abatement foam in unaffected devices may be placed in a different location due to device design.
Products not affected by this recall notification (U.S. only) / field safety notice (International Markets) include:
Trilogy Evo
Trilogy Evo OBM
Trilogy EV300
Trilogy 202
BiPAP A40 EFL
BiPAP A40 Pro
M-Series
DreamStation 2
Omnilab (original based on Harmony 2)
Dorma 100, Dorma 200, & REMStar SE
All oxygen concentrators, respiratory drug delivery products, airway clearance products.
Back to top
Questions and answers
Are affected devices safe for use? Should affected devices be removed from service?
The recall notification (U.S. only) / field safety notice (International Markets) advises patients and customers to take the following actions:
For patients using BiLevel PAP and CPAP devices: Discontinue use of affected units and consult with physicians to determine the benefits of continuing therapy and potential risks.
For patients using life-sustaining mechanical ventilator devices: DO NOT discontinue or alter prescribed therapy, without consulting physicians to determine appropriate next steps.
Philips is recommending that customers and patients halt use of ozone-related cleaning products, and adhere to their device Instructions for Use for approved cleaning methods.
Additionally, Philips is reminding customers and patients to review the age of their BiLevel PAP and CPAP devices, as they are typically recommended to be replaced after five years of use.
What is the safety hazard associated with this issue? Has Philips received any reports of patient harm due to this issue?
When will the correction for this issue begin? How long will it take to address all affected devices?
Are affected devices continuing to be manufactured and/or shipped?
Is this a recall? Have regulatory authorities classified the severity of the recall?
How will Philips address this issue? Are affected devices being replaced and/or repaired? Are customers entitled to a warranty replacement, repair, service, or other mitigations?
Are there any steps that customers, patients, users, and/or clinicians should take regarding this issue?
What is the cause of this issue? Was it a design, manufacture, supplier, or other problem?
How did this happen, and what is Philips doing to ensure it will not happen again?
What is meant by "high heat and humidity" being one of the causes of this issue?
Do affected units exhibit features that customers/users should watch out for? Particles or other visible issues?
Can Philips replace products under warranty or repair devices under warranty?
In those regions where Philips provides both patient care and devices, will new patients be set up with devices? Will existing patient devices that fail be replaced?
Is Philips certain that this issue is limited to the listed devices? Is there any possibility others are affected?
:pray: God Help Us!